8620
C. Cazorla et al. / Tetrahedron 67 (2011) 8615e8621
(CH3). HRMS EI: calculated for [C9H11NO]þ ¼149.0841,
found¼149.0838. Mp (MeOH) 61e62 ꢀC (white crystal).
(m, 4H), 1.48 (d, J¼6.8 Hz, 3H). 13C NMR (75 MHz, CDCl3):
d (ppm):
ꢃ
171.0 (Cq),143.2 (Cq),128.8 (2 CH),127.6 (CH),126.2 (2 CH),119.7 (Cq),
48.9 (CH), 35.6 (CH2), 24.9 (CH2), 24.7 (CH2), 21.9 (CH3), 17.1 (CH2)
(yellow oil).
4.4.4. N-(4-(Trifluoromethoxy)benzyl)acetamide
(16). 1H
NMR
(300 MHz, CDCl3):
d
(ppm): 7.28 (d, J¼8.6 Hz, 2H), 7.16 (d, J¼8.6 Hz,
2H), 6.04 (br, 1H), 4.40 (d, J¼5.8 Hz, 2H), 2.00 (s, 3H). 13C NMR
4.4.12. Methyl 4-((1-phenylethyl)carbamoyl) benzoate (30) [925136-
(75 MHz, CDCl3):
d
(ppm): 170.2 (Cq), 148.6 (Cq), 137.2 (Cq), 129.3 (2
89-6]. 1H NMR (300 MHz, CDCl3):
d
(ppm): 8.09 (d, J¼8.5 Hz, 2H),
CH), 121.3 (2 CH), 120.6 (q, JCeF¼254.5 Hz, CF3), 43.0 (CH2), 23.3
7.82 (d, J¼8.5 Hz, 2H), 7.35 (m, 5H), 6.34 (br, 1H), 5.35 (q, J¼6.9 Hz,
(CH3). 19F NMR (282 MHz, CDCl3):
d
(ppm): ꢁ58.4. HRMS EI: cal-
1H), 3.94 (s, 3H), 1.64 (d, J¼6.9 Hz, 3H). 13C NMR (75 MHz, CDCl3):
culated for [C10H10F3NO2]þ ¼233.0664, found¼233.0663. Mp
d (ppm): 166.4 (Cq), 165.8 (Cq), 142.9 (Cq), 138.6 (Cq), 132.9 (Cq),
ꢃ
(MeOH) 122e123 ꢀC (white crystal).
129.9 (2 CH),128.9 (2 CH),127.8 (CH),127.1 (2 CH),126.4 (2 CH), 52.5
(CH), 49.6 (CH3), 21.7 (CH3). EIMS m/z (% relative abundance): 283
(38), 268 (12), 163 (100), 135 (15), 120 (11), 104 (28), 103 (12), 77
(10). Mp (MeOH) 150e151 ꢀC (yellow crystal).
4.4.5. N-(Cyclohexyl)acetamide
(300 MHz, CDCl3): (ppm): 5.61 (br, 1H), 3.73 (m, 1H), 1.88e1.93
(m, 4H), 1.54e1.71 (m, 3H), 1.03e1.37 (m, 6H). 13C NMR (75 MHz,
(17)
[1124-53-4]. 1H
NMR
d
CDCl3):
d
(ppm): 169.4 (Cq), 48.5 (CH), 33.3 (2 CH2), 25.6 (CH2), 24.9
4.4.13. 4-Methyl-N-(1-phenylethyl)benzamide(31) [17537-45-0]. 1H
(2 CH2), 23.6 (CH3). HRMS EI: calculated for [C8H15NO]þ ¼141.1154,
NMR (300 MHz, CDCl3):
d
(ppm): 7.66 (d, J¼8.1 Hz, 2H), 7.20e7.40
ꢃ
found¼141.1147. (white foamy solid).
(m, 7H), 6.30 (br, 1H), 5.32 (q, J¼7.1 Hz, 1H), 2.38 (s, 3H), 1.60 (d,
J¼7.1 Hz, 3H). HRMS ESI: calculated for [C16H17NOþH]þ¼240.1388,
found¼240.1390 (white solid).
4.4.6. N-(1-Phenylethyl)cyclopropanecarboxamide (21) [78172-92-
6]. 1H NMR (300 MHz, CDCl3):
d
(ppm): 7.19e7.28 (m, 5H), 5.94 (br,
1H), 5.08 (q, J¼7.0 Hz,1H),1.42 (d, J¼7.0 Hz, 2H),1.19 (m,1H), 0.90 (m,
2H), 0.65 (m, 2H). 13C NMR (75 MHz, CDCl3):
(ppm): 172.7 (Cq),
4.4.14. N-(1-Phenylethyl)cinnamamide (32) [1004997-26-5]. 1H NMR
d
(300 MHz, CDCl3):
d
(ppm): 7.56 (d, J¼15.6 Hz, 1H), 7.38 (m, 2H),
143.5 (Cq),128.7 (2 CH),127.4 (CH),126.3 (2 CH), 48.9 (CH), 21.9 (CH),
7.23e7.29 (m, 7H), 7.18 (m, 1H), 6.35 (d, J¼15.6 Hz, 1H), 6.01 (br, 1H),
14.9 (CH3), 7.2 (2 CH2). HRMS EI: calculated for [C12H15NO]þ
:
5.21 (q, J¼7.2 Hz,1H),1.48 (d, J¼7.2 Hz, 3H).13C NMR (75 MHz, CDCl3):
ꢃ
189,1154, found¼189.1148. Mp (MeOH) 89e91 ꢀC (white crystal).
d (ppm): 165.1 (Cq),143.2 (Cq),141.3 (Cq),134.9 (CH),129.7 (CH),128.9
(2 CH),128.8 (2 CH),127.9 (2 CH),127.5 (CH),126.4 (2 CH),120.8 (CH),
4.4.7. N-(1-Phenylethyl)dodecanamide (22) [560090-64-4]. 1H NMR
(300 MHz, CDCl3): (ppm): 7.24e7.36 (m, 5H), 5.65 (br, 1H), 5.14 (q,
49.0 (CH), 21.7 (CH3). Mp (MeOH) 136e137 ꢀC (yellow crystal).
d
J¼7.1 Hz, 1H), 2.16 (t, J¼7.6 Hz, 2H), 1.48 (d, J¼7.1 Hz, 3H), 1.24 (m,
4.4.15. N-(1-Phenylethyl)aniline (33) [779-54-4]. 1H NMR (300 MHz,
CDCl3): d (ppm): 7.40 (m, 2H), 7.36 (m, 2H), 7.26 (m, 1H), 7.13 (t,
18H), 0.88 (t, J¼6.7 Hz, 3H). 13C NMR (75 MHz, CDCl3):
d
(ppm):
172.3 (Cq), 143.4 (Cq), 128.8 (2 CH), 127.5 (CH), 126.3 (2 CH), 48.7
(CH), 37.1 (CH2), 32.0 (CH2), 29.7 (CH2), 29.6 (2 CH2), 29.5 (2 CH2),
29.4 (CH2), 25.9 (CH2), 22.8 (CH2), 21.8 (CH3), 14.5 (CH3). HRMS EI:
J¼7.8 Hz, 1H), 6.69 (t, J¼7.3 Hz, 1H), 6.55 (d, J¼7.8 Hz, 2H), 4.53 (q,
J¼6.8 Hz, 1H), 1.55 (d, J¼6.8 Hz, 3H). 13C NMR (75 MHz, CDCl3):
d
(ppm): 147.4 (Cq), 145.3 (Cq), 129.2 (2 CH), 128.7 (2 CH), 127.0 (2
calculated for [C20H33NO]þ ¼303.2562, found¼303.2562. Mp
CH), 122.9 (CH), 117.4 (CH), 113.4 (2 CH), 53.6 (CH), 25.1 (CH3). EIMS
m/z (% relative abundance): 197 (41), 183 (13), 182 (100), 105 (53),
104 (15), 93 (35), 79 (10), 77 (26), 51 (12) (colorless oil).
ꢃ
(MeOH) 180 ꢀC degradation (yellow solid).
4.4.8. 2-Cyclopropyl-N-(1-phenylethyl)acetamide (23) [1201331-51-
2]. 1H NMR (300 MHz, CDCl3):
d
(ppm): 7.20e7.27 (m, 5H), 6.15 (br,
4.4.16. (1-Butoxyethyl)benzene (34) [4157-77-1]. 1H NMR (400 MHz,
1H), 5.11 (q, J¼7.2 Hz, 1H), 2.09 (d, J¼7.1 Hz, 2H), 1.43 (d, J¼7.2 Hz,
CDCl3):
d
(ppm): 7.19e7.27 (m, 5H), 4.32 (q, J¼6.3 Hz, 1H), 3.23 (t,
3H), 0.92 (m, 1H), 0.55 (m, 2H), 0.14 (m, 2H). 13C NMR (75 MHz,
J¼6.6 Hz, 2H),1.47 (m, 2H),1.36 (d, J¼6.3 Hz, 3H),1.28 (m, 2H), 0.82 (t,
CDCl3):
d
(ppm): 171.6 (Cq), 143.4 (Cq), 128.8 (2 CH), 127.4 (CH),
J¼7.3 Hz, 3H). 13C NMR (100 MHz, CDCl3):
d (ppm): 144.5 (Cq), 128.5
126.2 (2 CH), 48.6 (CH), 41.6 (CH2), 22.0 (CH), 7.2 (CH3), 4.7 (2 CH2).
(2 CH),127.4 (CH),126.2 (2 CH), 78.0 (CH), 68.6 (CH2), 39.2 (CH2), 24.3
(CH3), 19.5 (CH2), 14.0 (CH3). EIMS m/z (% relative abundance): 163
(71), 107 (100), 106 (23), 105 (82), 103 (12), 79 (41), 77 (24), 51 (15),
43 (21), 41 (25).
HRMS EI: calculated for [C13H17NO]þ ¼203.1310 found¼203.1307.
ꢃ
Mp (MeOH) 80e82 ꢀC (white crystal).
4.4.9. N-(1-Phenylethyl)hex-5-enamide (24). 1H NMR (300 MHz,
CDCl3):
d
(ppm): 7.18e7.29 (m, 5H), 5.95 (br,1H), 5.70 (m,1H), 5.10 (m,
4.4.17. 3-(1-Phenylethyl)benzo[b]thiophene (35) [114838-47-0]. 1H
1H), 4.91 (m, 2H), 2.09 (t, J¼7.8 Hz, 2H),1.97 (m, 2H),1.66 (m, 2H),1.40
NMR (400 MHz, DMSO-d6):
d
(ppm): 7.94 (d, J¼6.55 Hz, 1H), 7.63 (s,
(d, J¼7.0 Hz, 3H).13C NMR (75 MHz, CDCl3):
d
(ppm): 172.0 (Cq),143.4
1H), 7.61 (m, 1H), 7.26e7.35 (m, 6H), 7.14 (m, 1H), 4.48 (q, J¼7.2 Hz,
(Cq),137.9 (CH),128.7 (2 CH),127.3 (CH),126.2 (2 CH),115.3 (CH), 48.6
(CH), 35.9 (CH2), 33.2 (CH2), 24.8 (CH2), 21.8 (CH3). HRMS CI: calcu-
lated for [C14H19NOþH]þ¼218.1539, found¼218.1528 (yellow oil).
1H), 1.66 (d, J¼7.2 Hz, 3H). 13C NMR (100 MHz, DMSO-d6):
d (ppm):
145.5 (Cq), 140.2 (Cq), 139.9 (Cq), 138.2 (Cq), 128.4 (2 CH), 127.1 (2
CH), 126.1 (CH), 124.2 (CH), 123.8 (CH), 122.9 (CH), 122.3 (CH), 121.9
(CH), 38.5 (CH), 22.3 (CH3). EIMS m/z (% relative abundance): 238
(43), 224 (17), 223 (100), 222 (20), 221 (24) 178 (11).
4.4.10. N-(1-Phenylethyl)hex-5-ynamide (25). 1H NMR (300 MHz,
CDCl3):
d
(ppm): 7.23e7.33 (m, 5H), 6.12 (br, 1H), 5.09 (q, J¼6.9 Hz,
1H), 2.29 (t, J¼7.3 Hz, 2H), 2.22 (m, 2H), 1.95 (t, J¼2.6 Hz, 1H), 1.66
Acknowledgements
(m, 2H), 1.44 (d, J¼6.9 Hz, 3H). 13C NMR (75 MHz, CDCl3):
d (ppm):
171.4 (Cq), 143.3 (Cq), 128.6 (2 CH), 127.3 (CH), 126.1 (2 CH), 83.6
(CH), 69.3 (CH), 48.7 (CH2), 35.1 (CH2), 24.2 (CH2), 21.9 (CH), 17.8
(CH2). HRMS CI: calculated for [C14H17NOþH]þ¼216.1383,
found¼216.1367 (yellow oil).
C.C. thanks the French Ministry for teaching and research
(MESR) for financial support.
References and notes
4.4.11. 5-Cyano-N-(1-phenylethyl)pentanamide
(300 MHz, CDCl3): (ppm): 7.29e7.36 (m, 5H), 5.80 (br, 1H), 5.11 (q,
J¼6.8 Hz, 1H), 2.34 (t, J¼6.8 Hz, 2H), 2.22 (t, J¼6.8 Hz, 2H), 1.66e1.80
(28). 1H
NMR
1. Han, S.-Y.; Kim, Y.-A. Tetrahedron 2004, 60, 2447e2467.
2. (a) Ritter, J. J.; Minieri, P. P. J. Am. Chem. Soc. 1948, 70, 4045e4048; (b) Ritter, J. J.;
Kalish, J. J. Am. Chem. Soc. 1948, 70, 4048e4050.
d